Relay Therapeutics Inc.

NASDAQ: RLAY · Real-Time Price · USD
3.54
0.15 (4.42%)
At close: Aug 15, 2025, 3:59 PM
3.60
1.80%
After-hours: Aug 15, 2025, 07:53 PM EDT

Relay Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-337.71M -341.97M -290.51M -363.87M
Depreciation & Amortization
-6.85M 5.27M 4.13M 3.92M
Stock-Based Compensation
94.14M 86.03M 56.14M 48.45M
Other Working Capital
4.35M -35.28M 9.16M 18.62M
Other Non-Cash Items
-13.31M -17.18M -10.49M 137.69M
Deferred Income Tax
n/a n/a n/a 2.05M
Change in Working Capital
14.62M -32.46M 11.25M 97.34M
Operating Cash Flow
-249.11M -300.32M -229.49M -74.41M
Capital Expenditures
-2.02M -4.13M -9.06M -3.47M
Cash Acquisitions
n/a n/a 179.68M -25.3M
Purchase of Investments
-650.63M -385.54M -535.42M -980.66M
Sales Maturities Of Investments
611.46M 647.3M 355.74M 529.92M
Other Investing Acitivies
101K n/a -179.68M n/a
Investing Cash Flow
-41.08M 257.63M -188.75M -479.51M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.26M 4.47M 5.17M 5.88M
Financial Cash Flow
270.15M 34.75M 289.91M 388.09M
Net Cash Flow
-20.04M -7.93M -128.32M -165.83M
Free Cash Flow
-251.13M -304.44M -238.55M -77.88M